Maintaining genomic stability in the face of replication and recombination requires a huge variety of different damage response proteins. A cell's ability to decide when and where to deploy this DNA repair kit is critical to prevent tumor development. This issue's Select highlights recent studies that help to explain how these difficult decisions are made and reveals that some surprising cellular locations impact genomic stability.
Making DNA Repair Easier to Swallow
Histone deacetylases (HDACs) are known to have a broad range of substrates that function in many different biological pathways. Robert et al. (2011) now find that protein acetylation provides a potentially important link between the DNA-damage response and autophagy in yeast. Using an HDAC inhibitor, they find that HDAC activity is required for efficient DNA double-stranded break (DSB) repair. Part of the reason for this sensitivity appears to be a dramatic reduction in the expression level of the repair protein Sae2 upon HDAC inhibition. They show that two specific HDACs, Hda1 and Rpd3, are required for deacetylation of Sae2, and that in the absence of these HDACs, Sae2 is destabilized by acetylation. Unexpectedly, this destabilization depends on autophagy-a process more commonly associated with the clearance of large cytoplasmic structures such as protein aggregates and organelles. Blocking autophagy stabilizes Sae2, rescuing the DSB repair defect of HDAC mutant cells.
This intriguing result raises many questions about how and even why autophagy and DSB repair are coordinated. The authors propose that regulatory acetylation might ensure that potentially dangerous repair activity is spatially restricted within the nucleus (possibly close to nuclear pores, where the most severely damaged DNA is thought to accumulate). However, it remains to be seen whether acetylation specifically enhances the nuclear export of proteins such as Sae2, or whether the impact of acetylation acts further downstream to promote Sae2 targeting to the autophagic vacuole. Robert, T., et al. (2011). Nature 471, 74-79. 
The Silence of Senescence
Another recent study uncovers an alternative, more drastic mechanism used by cells to keep DNA-damage response (DDR) signaling under control. Activation of oncogenes deregulates DNA replication and increases the formation of DSBs. This results in sustained DDR activation, which is sufficient to drive cells into a protective, senescent state that blocks further proliferation. Oncogene-induced senescence is accompanied by large-scale changes in chromatin organization, which were initially proposed to act both locally to inhibit the expression of specific proliferative genes and more globally to shunt larger portions of the genome into a silenced, heterochromatic state. Until now, the function of this senescence-associated heterochromatin formation (SAHF) has been unclear. Di Micco et al. (2011) report that targeted gene silencing and SAHF represent two distinctly regulated pathways in human cells, with separable functions. Whereas local silencing depends on p53 and the ATM kinase cascade, and is required to prevent proliferation, SAHF depends on ATR kinase signaling and appears to specifically dampen the DNA-damage response.
What might the advantage be in downregulating this damage response in senescent cells? The authors show that disrupting SAHF, by promoting histone acetylation and chromatin decondensation, increases DDR signaling and leads to apoptosis, both in oncogene-transformed human cultured epithelial cells and in mouse xenografts. SAHF might therefore act as a protective response to maintain senescent cell viability. The physiological benefits conferred by this strategy are unclear. Senescent cells are thought to play a non-cell-autonomous role by secreting immune modulators to recruit the innate immune response. Perhaps keeping senescent cells alive represents a more effective means of tumor suppression than relying on cell-autonomous mechanisms to limit the growth of transformed cells. Di Micco, R., et al. (2011). Nat. Cell Biol. 13, 292-302. 
Aging Telomeres Hit the Power Switch
Progressive loss of the telomeres protecting chromosome ends is thought to be one of the major factors driving replicative senescence and cellular aging. Consistent with this, telomerase-deficient mice succumb to premature aging, characterized by functional decline in multiple tissues. Interestingly, this decline is not limited to organs with rapid cellular turnover, which experience classical DNA-damage checkpoint responses such as senescence and apoptosis, but also affects more quiescent tissues such as the heart and liver, manifesting as heart failure and impaired metabolism. How can telomere loss impair the function of such nonreplicating cells?
A recent study now provides a possible explanation, revealing that uncapped telomeres can repress key regulators of mitochondrial biogenesis and function. Mitochondrial functional decline is a known hallmark of aging tissues and senescent cells in culture. Sahin et al. (2011) show that activation of the p53-dependent nuclear DNA-damage response by shortened telomeres impairs mitochondrial function in telomerase-deficient mice. p53 acts to suppress the transcription of the mitochondrial regulators Pgc1a and Pgc1b, leading to reduced mitochondrial DNA content and ATP synthesis. Strikingly, inhibition of p53 not only restores mitochondrial DNA copy number but also is sufficient to partially rescue the defective gluconeogenesis and cardiac function observed in telomerase-deficient mice. These findings therefore forge a direct molecular link between the telomeric and mitochondrial theories of aging, paving the way for future work to establish the relative contributions of nuclear DNA-damage checkpoint responses and mitochondrial decline in the aging of different tissues. Sahin, E., et al. (2011) . Nature 470, [359] [360] [361] [362] [363] [364] [365] (X + Y)/2 = ?
Not all DNA damage is a sign of trouble ahead. The regulated formation of DSBs by the Spo11 protein during meiosis, for example, is crucial for pairing and recombination between homologous chromosomes and thereby promotes accurate chromosome segregation and genetic diversity. However, male meiosis presents a particular challenge for the cell: how to pair-up and accurately segregate the mostly nonhomologous X and Y chromosomes. Unlike their autosomal counterparts, X and Y cannot depend on multiple contacts along the length of the chromosome to ensure stable pairing. Instead, they rely upon a relatively small stretch of DNA, present on both the X and Y chromosomes, called the pseudoautosomal region (PAR). Kauppi et al. (2011) now shed light on the mysterious process of PAR pairing and recombination. They find that XY pairing occurs late during meiosis, and PAR DSBs form in most cells within a narrow time-window after the repair of autosomal DSBs has commenced. The frequency of DSBs within the PAR is significantly increased relative to that in other regions of the genome. This fact may perhaps be explained by the authors' observations that the region forms shorter, more frequent chromatin loops, potentially increasing the accessibility of PAR DNA to Spo11.
Taken together, the findings suggest that PAR recombination likely depends on a set of regulators distinct from that of other chromosomes. This conclusion is further strengthened by genetic experiments that specifically ablate splice variants of Spo11. Female mice lacking Spo11a (which appears relatively late in meiosis) but expressing Spo11b apparently undergo normal levels of meiotic recombination, whereas male mice of the same genotype fail to establish PAR DSBs and XY pairing in most cells. Armed with this information, it should now be possible to dissect in further detail the molecular mechanisms that ensure reliable segregation of sex chromosomes. Kauppi, L., et al. (2011) . Science 331, [916] [917] [918] [919] [920] .
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The aging heart. Mice lacking telomeres develop defects, including thinning of the left ventricular wall, in quiescent tissues such as the heart. When X meets Y. Mouse spermatocyte chromosomes labeled with antibodies against SYCP3 (red) and SYCP1 (green). In the absence of Spo11a (lower panel), X and Y chromosomes (red) fail to associate and recombine.
